ClinicalTrials.Veeva

Menu

SedLine Engineering Data Collection Study in Pediatric Patients Undergoing General Anesthesia or Sedation

Masimo logo

Masimo

Status

Terminated

Conditions

Anesthesia

Treatments

Device: Pediatric SedLine forehead EEG sensor

Study type

Interventional

Funder types

Industry

Identifiers

NCT03128931
HAMM0001

Details and patient eligibility

About

The purpose of the study is to collect EEG data with the Masimo SedLine device along with vital signs, patient demographics, anesthetic record and surgical procedure during general anesthesia or sedation.

Enrollment

45 patients

Sex

All

Ages

12 months to 17 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients 17 years old and younger
  • ASA status I, II, or III.
  • Scheduled for surgical and non-surgical procedures scheduled under general anesthesia or sedation (Common procedures include but are not restricted to tonsillectomy, adenoidectomy, urological procedures, dental rehabilitation, orthopedic procedures, biopsies, audiogram, nuclear scans, gastroscopy, colonoscopy, etc. Surgery can be open, laparoscopic, or robotic).

Exclusion criteria

  • Any deformities or devices that may prevent application of SedLine Array to forehead with a proper fit.
  • Cases in which a rapid sequence induction is indicated (emergency, full stomach precautions).
  • Subjects who are developmentally delayed.
  • Subjects deemed not suitable for study at the discretion of the investigator.

Trial design

Primary purpose

Other

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

45 participants in 1 patient group

Test Group
Experimental group
Description:
The subjects will be enrolled in the test group and will receive the Pediatric SedLine forehead EEG sensor.
Treatment:
Device: Pediatric SedLine forehead EEG sensor

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems